NICM
IRWD icon

Neo Ivy Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Neo Ivy Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-10,081
Closed -$134K – 501
2019
Q4 		$134K Buy
+10,081
New +$111K 0.16% 178

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Neo Ivy Capital Management's IRWD Position: Q1 2020 in Review

Neo Ivy Capital Management sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2020, closing a stake of 10,081 shares — an estimated $134K sold.

Neo Ivy Capital Management first reported a position in IRWD in Q4 2019 and held it in 1 quarter. The position peaked at $134K in Q4 2019. 193 funds tracked by Wall St. Rank hold IRWD as of Q1 2020.

  • Neo Ivy Capital Management reported no remaining Ironwood Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Neo Ivy Capital Management sold 10,081 Ironwood Pharmaceuticals shares in Q1 2020, an estimated $134K.
  • Neo Ivy Capital Management first reported a position in Ironwood Pharmaceuticals in Q4 2019 and held it in 1 quarter.
  • Neo Ivy Capital Management's Ironwood Pharmaceuticals position peaked at $134K in Q4 2019.
  • 193 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2020.

Based on Neo Ivy Capital Management's 13F filing for Q1 2020, filed 15 May 2020.